Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
An investigative study into the recovery index, attentiveness and state of memory after xenon or isoflurane anaesthesia
ISRCTN ISRCTN01110844
ClinicalTrials.gov identifier
Public title An investigative study into the recovery index, attentiveness and state of memory after xenon or isoflurane anaesthesia
Scientific title A single centre randomised controlled investigative study into the recovery index, attentiveness and state of memory after xenon or isoflurane anaesthesia
Acronym N/A
Serial number at source 23/2002
Study hypothesis The aim of the study was to evaluate the efficacy of two balanced anaesthetic regimens with respect to recovery of early post-operative cognitive function at the day of operation (assessed as attentiveness and memory; this was the primary criterion) and emergence profile (assessed as the recovery index; this was the secondary criterion). The hypothesis was primarily that patients have a significantly higher status of attentiveness and memory 1 and 3 hours after inhalation anaesthesia with xenon compared to isoflurane anaesthesia, and that patients reach their pre-operative level of cognitive function within 3 hours after extubation. The second hypotheses was that the time to wake up from the anaesthetic was predicted to be shorter following xenon than following isoflurane.
Lay summary
Ethics approval Ethics Committee of the University Witten/Herdecke approved on the 11th September 2002 (ref: 23/2002). Patient insurance by Winterthur International (ref: DE 00020283-LI-02A-715).
Study design Single centre single blind randomised controlled trial
Countries of recruitment Germany
Disease/condition/study domain Post-operative cognitive function
Participants - inclusion criteria 1. Healthy American Society of Anaesthesiologists (ASA) grade I and II patients
2. Aged over 18 years of age, either sex
3. Scheduled for four different types of elective surgery. The types of surgery were:
3.1. Visceral surgical strumectomy
3.2. Augmentation or reduction mammaplasty
3.3. Liposuction in obese patients
3.4. Knee arthroscopy
Participants - exclusion criteria 1. Patients with ASA classification grade greater than 2
2. Aged less than 18 years
3. Emergency surgery
4. Alcohol or drug abuse
5. Organ dysfunction of liver, kidney or pulmonary system
6. Diabetes
Anticipated start date 01/06/2003
Anticipated end date 31/05/2005
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 61
Interventions ASA I and II patients undergoing both long and short surgical interventions were randomised to receive either general anaesthesia with xenon or general anaesthesia with isoflurane. The inhalational anaesthesia was carried out following standard procedures using appropriate equipment.

Patients were randomised in blocks of 4 - 8 patients in order to balance the groups. The varying size of blocks was to counteract the differing frequencies of the operations and also any influence of duration and invasiveness of the operations. A total of 61 patients who met the pre-defined inclusion and exclusion criteria were randomised either to receive xenon in oxygen (Xenon group, n = 31) or isoflurane in stickoxydal (Isoflurane group, n = 30).
Primary outcome measure(s) Syndrome Short Test
Secondary outcome measure(s) 1. Recovery Index
2. Aldrete Score
Sources of funding Messer Griesheim/AIR LIQUIDE Medical GmbH (Germany)
Trial website
Publications 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20459661
Contact name Dr  Ralph  Stuttmann
  Address Mersburgerstraße 165
  City/town Halle ( Saale)
  Zip/Postcode 06112
  Country Germany
  Email ralph.stuttmann@bergmannstrost.com
Sponsor BG-Kliniken Bergmannstrost (Germany)
  Address c/o PD Dr. med. Ralph Stuttmann
Merseburgerstraße 165
  City/town Halle
  Zip/Postcode 06112
  Country Germany
  Email ralph.stuttmann@bergmannstrost.com
  Sponsor website: http://www.bergmannstrost.com
Date applied 30/12/2009
Last edited 25/05/2010
Date ISRCTN assigned 16/03/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central